Posted by Michael Wonder on 05 Jun 2018
Urgent appeal for migraine sufferers to access new treatment
5 June 2018 - 6 June deadline for submissions to PBAC.
Headache Australia is urging migraine sufferers to help a breakthrough migraine treatment be added to the PBS.
Aimovig (also known as Erenumab) is preventative, reducing episodes by at least 50 percent in clinical trials.
The deadline for submissions to the PBAC, who decides which drugs are added to the PBS, is June 6. Without PBS support, the cost will be most likely beyond the affordability of many of Australia’s estimated five million migraine sufferers.
